By Mariam Sunny and Kamal Choudhury (Reuters) -The U.S. Food and Drug Administration has approved a prefilled syringe version ...

The prefilled syringe version was approved to treat adult patients with a muscle-weakening genetic disease called generalized myasthenia gravis (gMG) and another rare, immune-mediated nerve ...